Cambridge Healthtech Institute’s Inaugural

Characterization and Development of Vaccines

January 19-20, 2023

Vaccines and mRNA-based vaccines have recently gained a lot of attention due to COVID-19. Cambridge Healthtech Institute’s Characterization and Development of Vaccines tackles the practical challenges facing the development, analysis, and characterization of a variety of vaccines including COVID-19 and for other indications. Experts will delve into topics such as CMC under accelerated timelines, utilizing new technologies, ensuring product quality, formulation, and delivery, and managing complex supply chains. If you have a new and interesting research story or a case study to share with your peers, we would like to hear from you and look forward to receiving your speaking proposal.

This conference is part of the Characterization of Biotherapeutics & Vaccines Pipeline which also features the 9^th Annual Characterization of Biotherapeutics conference and the 14^th Annual Characterizing Protein Aggregates and Impurities.

Coverage will include, but is not limited to:

Development and manufacturing consideration from vaccine policy, safety and risk development point-of-view
COVID-19 vaccine updates
Lessons learned from COVID-19 and preparing for the next pandemic
Development and characterization of viral vectors, vaccines, oncolytic viruses, exosomes, and other no-viral vaccine delivery systems
AI/ML in vaccine development
Formulation strategies for wider distribution of vaccines
Formulation, product development, stability, and delivery
Lipid nanoparticles for vaccine delivery

The deadline for priority consideration is July 1, 2022.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: